Heat shock proteins represent the major elements of the cellular stress response that protects cells from diseases caused by protein misfolding. Small-molecule amplifiers of heat shock proteins have shown promising results in several animal models, demonstrating the potential importance of such compounds for therapeutics. The expression of many heat shock proteins is controlled by HSF1, which forms stress granules in the nucleus when transcriptionally activated. Activation of the cellular stress also correlates with the translocation of HSP70 into nucleoli. The authors have developed an image-based, multiparametric assay to simultaneously monitor the effects of compounds on HSF1/HSP70 stress granule formation in heat-shocked Hela cells. Highcontent screening of the compound library was performed with a Z′ of 0.62, demonstrating a highly robust assay for large-scale screening. The resulting hits showed prolonged amplification of HSP70 induction in heat-stressed cells but no effects in cells without stress. Treatment of cells with selected hits exhibited significant cytoprotection from both oxygen glucose deprivation and rotenone-induced stresses. Thus, high-content screening of HSF1/HSP70 amplifiers provides a practical opportunity for clinical therapeutics targeting protein misfolding diseases. (Journal of Biomolecular Screening 2008:953-959) 
INTRODUCTION

H
EAT SHOCK TRANSCRIPTION FACTOR 1 (HSF1) is a prototype regulator that activates gene transcription of heat shock proteins (HSPs) through binding heat shock element in the promoter region.
1 HSF1 maintains its inactive monomeric form in the cytoplasm and nucleus under normal growth conditions. In stress-stimulated cells, HSF1 undergoes trimerization with enhanced DNA binding capacity. The activity is further elevated through certain sites of inducible phosphorylation. 1 Most importantly, HSF1 redistributes from a widely diffused pattern to a few granules within the nucleus of stressed cells. 2 It has been reported that these stress granules are primarily located at the 9q12 region through direct DNA-protein interaction with satellite III repeats. 3, 4 The kinetics of HSF1 granule formation correlates well with the transcriptional activity of HSF1, suggesting a highly reliable indicator for measuring HSF1 activity. 2, 5 HSP70 protein is one of the most important and abundant molecular chaperones. 6 The major function of HSP70 is to provide cytoprotection against stress-induced protein misfolding or denaturation. In addition, constitutively expressed HSP70 protein also plays important housekeeping roles in nonstressed cells. 6 Following heat shock, there is a significant increase of HSP expression, and the majority of newly synthesized HSP70 rapidly migrates into the nucleus. Using GFP fusion HSP70, Zeng et al. 7 reported that GFP-HSP70 exhibits a significantly increased signal and becomes highly concentrated in the nucleoli, designated as the HSP70 granule. The formation of HSP70 granule strictly coincides with the presence of HSF1 granules and is significantly downregulated in thermotolerant cells. 8 There is also a negative feedback loop to balance the expression of HSPs. Accumulation of HSP90 can lead to the reassociation of the HSP90/HSF1 complex and termination of HSP transcription. 9 Several therapeutically active small molecules modulating HSF1/HSPs in the cellular stress response have been reported. 10 Many compounds have been identified as HSF1 modulators via direct HSF1 activation (celastrol), HSP90 inhibition (radicicol, 17-AAG), HSF1/HSP70 coinduction (arimoclomol, bimoclomol, and iroxanadine), and so on. 10, 11 In recent years, modulation of chaperones has emerged as a new area for therapeutic intervention. Upregulation of HSPs, especially HSP70, via small molecules has shown great therapeutic value in the disease area, where the major cause is the accumulation of misfolded proteins. 11 Particularly, some compounds (such as arimoclomol) in this category do not induce HSP70 and other chaperone proteins de novo in normal cells but only amplify the already enhanced chaperone expression (so-called coinduction or amplification) in stressed or diseased cells. Such a unique molecular mechanism offers a valuable therapeutic strategy with limited side effects. 11 The goal of this study is to develop a high-content screening assay to identify small molecules that coinduce or amplify the HSF1/HSP stress response for use as targeted chaperone therapies. So far, there is no executable assay to screen compounds that directly measure the activation of HSF1/HSP in a highthroughput format. Zaarur et al. 12 reported a biochemical assay to screen for HSP90 inhibitor and used heat-sensitive luciferase as an indicator to indirectly measure HSF1/HSP activity. Because both HSF1 and HSP70 form stress granules after heat shock, we chose image-based high-content screening (HCS) as a platform for accurate quantification of stress granules for correlation with HSF1/HSP70 activity. The assay reported here demonstrates how advanced technology such as HCS can address complicated biological questions.
MATERIALS AND METHODS
Chemical reagents and cell lines
All reagents were of analytical grade. Celastrol was purchased from Calbiochem (San Diego, CA). HSP70 monoclonal antibody (catalog # SPA-810) and HSF1 polyclonal antibody (catalog # SPA-901) were obtained from Stressgen (Ann Arbor, MI). Paraformaldehyde was purchased from EMS (Hatfield, PA). FITC-labeled antimouse antibodies (catalog # 115-096-146) and rhodamine-labeled antirabbit antibodies (catalog # 711-295-152) were purchased from Jackson ImmunoResearch (West Grove, PA). Hela and SH-SY5Y cells were purchased from ATCC (Manassas, VA). All cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS; v/v), 10 mM L-glutamine, and 10 mM HEPES. Cells were subcultured using 0.25% trypsin-EDTA when confluence was estimated at 80% to 90%. Subcultured cells within 10 passages were routinely used for HCS assays.
Compound library management
A total of 1600 compounds from the Cytrx internal library were used for HCS screening. Compounds in master plates were prepared at a concentration of 6 mM for screening in DMSO. Positive controls were allocated in column 1, whereas DMSO controls were placed in column 12 in V-bottomed 96-well plates (Costar 3363).
Heat shock stress
Hela cells were pretreated with compounds 1 h before heat shock at 41 °C for 2 h. The overall dilution of compound in DMEM was 200-fold, with a final concentration of 30 μM for screening. To achieve constant temperature for the entire 96-well plate with minimal variability, we made a custom-made aluminum plate for better heat transduction. The aluminum plate was placed inside the incubator at 41 °C the day before experiment.
High-content screening assay for the quantification of HSF1/HSP70 stress granules
Immunocytochemical staining for HSF1 and HSP70 in Hela cells was performed following the previous publication with some modifications. 13 Image acquisition was performed using an INcell 1000 (GE Healthcare, Piscataway, NJ) integrated with a Twister II (Caliper Life Sciences, Hopkinton, MA) for automated plate delivery. Image analysis was carried out using Multi Target Analysis module from Workstation 3.6. Algorithms for the HSF1/HSP70 total granule count, granule area, and nuclear intensity coefficient of variation (CV) were established according to assay conditions and manufacture instructions. EC 50 values and curve fitting were performed using Prism 4.0 (GraphPad Software, San Diego, CA) with nonlinear regression analysis.
Oxygen glucose deprivation and rotenone model systems
SHSY5Y cells were plated at a density of 25,000 cells/well in 96-well plates precoated with collagen I (BD Biosciences, San Diego, CA) and grown for 16 to 24 h in complete medium. For the induction of oxygen glucose deprivation (OGD), cells were washed twice in pre-deoxygenated medium with no glucose or serum. Selected compounds were added to the cells after medium change within 1 h before OGD stress, and the plates were placed in modular incubator chambers (Billups-Rothenberg, Del Mar, CA). The chambers were flushed with a gas mixture of 95% N 2 /5% CO 2 at a flow rate of 10 L/min for 30 min at room temperature. The residual O 2 concentration was monitored with a final concentration less than 1%. After flushing, the chambers were sealed and maintained in a 37 °C incubator for 28 h. Rotenone treatment was initiated with a final concentration of 100 nM for 24 h. MTS assay was performed to determine cell viability according to the published protocol.
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RESULTS AND DISCUSSION
Optimization of heat shock screening conditions for HCS granule assay
In the HCS setting, we used a known HSF1 activator, celastrol, 14 as the assay positive control. Notably, celastrol can induce HSF1 activity in both stressed and nonstressed cells (data not shown). Thus, celastrol does not meet the preset definition to be an HSF1 amplifier. For heat shock-based screening, 2 technical challenges have to be overcome. First, the temperature and time of heat shock have to be optimized. Different heat shock temperatures and recovery times have been reported in the literature. 2, 14 Higher temperature (such as 43 °C) leads to a significantly high background in DMSO-treated samples, 14 diminishing the signal/noise ratio of compound amplification effects. The optimized condition was selected empirically to be at 41 °C for 2 h with no recovery time, under which a satisfactory window was observed for HSF1/HSP70 granule formation induced by 2 μM celastrol (Fig. 1A, C) as compared with DMSO solvent control (Fig. 1B, D) . Second, it is difficult to ensure that heat is evenly transduced to each well when the heat shock experiment is performed in a 96-well or higher well plate format. When regular air heat (from an incubator) was used for the heat shock experiment, we have observed a large variability (CV >40%) of the HSF1/HSP70 granule count throughout the 96-well plate (data not shown). A high-throughput heat shock method was reported previously to immerse the plates in a 45 °C water bath, which is not suitable for the image-based high-content method. 12 The solution is to use a custom-made aluminum plate for quick heat transduction, which allowed us to perform 96-well plate-based heat shock with a relatively low CV (7.94%) for the HSF1 granule count.
Quantification of HSF1/HSP stress granules and assay validation
The Multi Target Analysis (MTA) module from Workstation software (GE Healthcare) provides a high-speed measurement of nuclear granules, including granule count, granule area, granule intensity, and nuclear intensity CV (which measures CV of pixel intensity in the nucleus). As shown in Figure 2 , we chose to use granule count and nuclear intensity CV for the quantification of HSF1 granules ( Fig. 2A, B) , whereas granule count and granule area were adopted for measuring the signal of HSP70 granules (Fig. 2C, D) .
The data in Figure 2A indicate that heat shock (41 °C for 2 h) induced an average 5.34 ± 0.72 HSF1 stress granules per nucleus in Hela cells exposed to 2 μM celastrol as quantified by MTA. By comparison, DMSO-treated cells contain 2.46 ± 0.22 granules. To achieve a relatively low background, we decided to use 5 as the threshold for the HSF1 granule count induced by compound treatment. Hela cells that contained more than 5 HSF1 granules were designated as "HSF1 granule-positive cells." The thresholds for HSF1 nuclear intensity CV, HSP70 granule count, and HSP70 granule area were also chosen with gating values equivalent to the average of DMSO-treated samples plus 2 or more standard deviations (Fig. 2B-D 
FIG. 2.
Quantification of HSF1/HSP70 stress granules. Four different parameters were adopted for data analysis. Granule count and nuclear intensity coefficient of variation (CV) were used for the quantification of nuclear HSF1 granules (A, B) ; granule count and granule total area were used for the quantification of nuclear HSP70 granules (C, D). The differences of the mean values were compared by the Student t test. A p-value <0.01 (**) was considered statistically significant.
The HCS granule assay was further validated for robotic high-throughput operation with the Sciclone liquid handling system (Caliper Life Sciences, Hopkinton, MA). Celastroltreated samples from 20 HCS assay plates were collected for calculating Z′ with an average value of 0.62, demonstrating a reasonably performed robotic assay (Fig. 3A) . An average of 59.36% ± 4.71% HSF1 granule-positive cells was observed with a tight CV value (7.94%) as compared with that of DMSO control at 8.17% ± 2.00%. The signal-to-noise ratio of celastrol is 7.13, indicating a significantly improved assay window when the heat shock experiment was conducted at 41 °C (compared to 43 °C; data not shown). Eleven hits were confirmed after screening of 1600 in-house compounds with a false-positive rate of 15.4% (Fig. 3A, inset) .
Identification of compounds that coinduce HSF1/HSP with cytoprotective effects
Several positive hits from the initial high-throughput campaign were selected to examine the dose dependency for HSF1/HSP70 coinduction. As shown in Figure 3B , compound A exhibited an EC 50 value of 10.1 μM using the percentage of positively stained cells (gating with the threshold of HSF1 nuclear intensity CV). Celastrol exhibited an EC 50 value of 1.32 μM, agreeing well with the previously published EC 50 value of 3 μM.
14 EC 50 values for HSP70 induction at 2 h after heat shock were also determined (gating with the threshold of HSP70 granule total area; Fig. 3C ). Unlike celastrol, compound A does not stimulate or induce HSF1/HSP70 granule formation when there is no heat shock stress, suggesting that it is a candidate for chaperone amplification (data not shown). Figure 3D shows the time course study for compound A and celastrol-induced HSF1/HSP70 activation after heat shock. The concentrations in this study are 1 μM and 10 μM for celastrol and compound A, respectively, which are close to their EC 50 values. Compound A exhibits a stress response similar to celastrol at most of time points tested. Both compounds activate HSF1 stress granules for up to 6 h after heat shock, suggesting that they may stabilize the active conformation of HSF1 for continuous induction of HSPs. At 1 h after heat shock, we have observed that 30% to 40% of cells are HSF1+HSP70+. The rest of the cells are HSF1-HSP70+ (~30%), HSF1+HSP-(~30%), and HSF1-HSP-(~10%). The HSP70 signal maintains a relatively high level 6 h after completion of heat shock. The longlasting expression of HSP70 provides an extended protection window for restoring misfolded proteins. Next we want to investigate the cytoprotective effects of these hits in biologically relevant models. OGD is a cell-based system of ischemia and stroke. Cytotoxicity induced by OGD is at least partly due to protein misfolding and aggregation. 15 The rotenone model of Parkinson's disease is another cell-based system for the study of protein aggregation-induced cytotoxicity. 16 It has been reported that the mitochondria inhibitor rotenone can significantly increase α-synuclein expression, which eventually becomes cytoplasmic inclusions similar to Lewy bodies. 16 As shown in Figure  4A , we observed a 91% increase of viable SH-SY5Y cells when pretreated with 2.5 μM of compound A, exhibiting significantly in OGD model cytoprotective effects. Notably, there is no difference of cell viability when SH-SY5Y cells were treated with compound A and DMSO at a normal (no stress) condition. As for the rotenone model, more than 42% of SH-SY5Y cells were killed when 100 nM of rotenone was applied for 24 h (Fig. 4B) . Pretreated SH-SY5Y with 2.5 μM of compound A resulted in a 29% increase of cell viability compared with that of DMSO control (Fig. 4B) . The detailed cytoprotective mechanisms, possibly through HSF1/HSP amplification, are currently under investigation.
The HCS granule assay reported here allows direct identification of novel chemical entities that can amplify HSF1/HSP70 expression under stress conditions. Compared with conventional Western blot or immunofluorescence assays, we believe that the HCS granule assay reported here is superior with the following advantages: (1) HSF1/HSP70 stress granules are well correlated with HSF1 and HSP70 activation. Quantification of HSF1/HSP70 granules can measure cellular kinetics of HSF1/HSP70 activity in response to various stressors. Moreover, an improved signal/background ratio was obtained with a better window for compound screening when a mild stress condition (heat shock at 41 °C) was applied. This setting also allowed us to identify hits with weak induction activity, which we have observed in the high-throughput campaign (data not shown). (2) The advanced software system of HCS creates a significantly improved platform for complicated image segmentation, cell sorting and analysis, calculation of granule count/area, high-speed data processing, and so on. In addition, HCS also offers many other phenotypic parameters for compound evaluation. For example, we can compare different compound-induced nuclear phenotypic changes (DAPI staining) in the presence or absence of heat shock treatment, which can be particularly helpful for prediction of cytotoxicity. (3) The automatic feature of HCS makes it possible to screen for a large compound library at a reasonable throughput. (4) The multiplexing nature of HCS assays can be particularly useful in teasing apart complicated biological pathways, which provides a valuable tool to rapidly identify potential targets and biomarkers. In the future, the major technical hurdle in heat shock-based HCS is to further improve heat shock operation in a higher (384-well or above) throughput format. To this end, a streamlined data-processing capacity will be necessary to accelerate the process. 
